KAO
2.5
237.8%
CTD
2.25
-86%
VR8
0.027
92.9%
STG
0.145
-37%
AM7
0.065
62.5%
CHM
0.008
-27.3%
PR2
0.068
58.1%
REG
4.54
-27%
IRD
0.011
57.1%
GTN
0.195
-26.4%
WSI
0.085
51.8%
ARO
0.003
-25%
GGM
0.25
47.1%
BLU
0.003
-25%
WEC
0.305
41.9%
AIH
0.41
-21.2%
SOP
0.075
41.5%
SEQ
0.071
-20.2%
AS2
0.007
40%
BNL
0.004
-20%
EXR
0.065
35.4%
CCE
0.2
-20%
TET
0.375
33.9%
EVR
0.004
-20%
SER
0.2
33.3%
SIS
0.004
-20%
RAP
0.03
30.4%
IRI
0.29
-19.4%
NAG
0.013
30%
MX1
0.022
-18.5%
C29
0.022
29.4%
BST
0.315
-18.2%
XRA
0.29
28.9%
TTT
0.14
-17.6%
BAP
0.875
28.7%
TRJ
0.17
-17.1%
AHL
1.58
27.9%
ACS
0.29
-17.1%
FTI
0.8
27%
GBL
0.015
-16.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Noxopharm (ASX:NOX): New data shows Sofra™ activates immune cells against dying cancer

Transcription of The Stock Network Interview with Noxopharm (ASX:NOX), CEO Olivier Laczka Lel Smits: Noxopharm has generated new preclinical data showing its Sofra technology can activate immune cells in response to dying cancer cells. The study found that dying cancer cells alone did not trigger an immune response, but combining them with Noxopharm’s TLR8 drug […]

Metals Australia (ASX:MLS): Unlocking new value across graphite and critical minerals

Transcription of The Stock Network Interview with Metals Australia (ASX:MLS), CEO Paul Ferguson Lel Smits: Metals Australia is progressing a diverse portfolio of critical and strategic mineral projects across Australia and Canada, with new exploration and development opportunities emerging alongside its flagship Lackahill Graphite project. I’m joined today by CEO Paul Ferguson to discuss the […]

Starpharma (ASX:SPL, US OTC:SPHRY): Building the future of biotech in the age of AI

Transcription of The Stock Network Interview with Starpharma (ASX:SPL, US OTC:SPHRY), Chief Executive Officer Cheryl Maley Lel Smits: As AI transforms drug discovery and development, the opportunity to harness new technology while keeping patients’ scientific outcomes and long-term shareholder value at the centre is evolving. Starpharma is advancing its Dendrima technology across areas, including oncology, while […]

Smart Parking (ASX:SPZ): AI-powered transformation driving record results and global expansion

Transcription of The Stock Network Interview with Smart Parking (ASX:SPZ), CEO Paul Gillespie Lel Smits: Smart Parking has delivered a record FY26 with its proprietary technology and AI capabilities playing an increasingly important role in scaling the business across global markets. The company is expanding its automatic number plate recognition platform across the UK, US, […]

Kincora Copper (ASX/TSXV: KCC): Drilling, AI targets and new partnerships advancing NSW portfolio

Transcription of The Stock Network Interview with Kincora Copper (ASX/TSXV: KCC), President and CEO Sam Spring Lel Smits: Kincora Copper continues to advance its hybrid prospect generator strategy, with partner funded drilling at Nevatized South, nine holes completed at Condobolin, and new exploration targets generated through AI and traditional geological reviews. The company is also […]

SCX.ai Holdings (ASX:SCX): Listing day puts Australia’s AI infrastructure opportunity in focus

Transcription of The Stock Network Interview with SCX.ai Holdings (ASX:SCX), CEO David Keane Lel Smits: SCX.AI Holdings has officially listed on the ASX today, becoming one of Australia’s newest CurePlace Sovereign AI infrastructure companies, following its $40 million IPO. As AI moves rapidly from experimentation into everyday enterprise and government use, the company is targeting […]

Metals Australia (ASX:MLS): Advancing a portfolio of critical and strategic mineral opportunities

Transcription of The Stock Network Interview with Metals Australia (ASX:MLS), CEO Paul Ferguson Lel Smits: Metals Australia is advancing critical base and precious metals projects across Canada and Australia. Its flagship Lac-Cahil graphite project in Canada has completed an upstream pre-feasibility study and downstream preliminary economic assessment, while Menindee and other Australian projects provide further […]

Chariot Resources (ASX:CC9): Partner-funded drilling targets Nigerian lithium

Transcription of The Stock Network Interview with Chariot Resources (ASX:CC9), Chair and Managing Director Shanthar Pathmanathan Lel Smits: Chariot Resources has just signed a term sheet with CND, Xiongnu and CNC Minerals for a proposed partner-funded drilling, trial mining and DSO offtake program across one Nigerian lithium project. Xiongnu would fund at least 1,500 metres […]

Amaero Inc (ASX:3DA): US defence, critical metals, manufacturing growth & Nasdaq IPO

Transcription of The Stock Network Interview with Amaero Inc (ASX:3DA), Chairman & CEO Hank Holland Lel Smits: Amaero is developing a critical metals alloy power manufacturing facility in Tennessee, USA, targeting high-value powders for mission-critical defense, aerospace, and space applications. Amaero is ramping up production, has also secured a $6.5 million, 13-month U.S. Department of […]